Accellta CEO Says Israeli Stem Cell Specialist Seeks Global Partners
Executive Summary
Accellta CEO Itzchak Angel tells Sten Stovall about the Israeli group's stem cell culturing processes and future expansion plans, including a planned $15m capital-raising exercise and ongoing search for future corporate partners.